Cargando…
BN 52021 (a platelet activating factor-receptor antagonist) decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis.
Several lines of research indirectly suggest that platelet activating factor (PAF) may intervene in the pathogenesis of extrinsic allergic alveolitis (EAA). The specific aim of our study was to evaluate the participation of PAF on macrophage activation during the acute phase of EAA in an experimenta...
Autores principales: | Pérez-Arellano, J L, Martín, T, López-Novoa, J M, Sánchez, M L, Montero, A, Jiménez, A |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781835/ https://www.ncbi.nlm.nih.gov/pubmed/9705608 |
Ejemplares similares
-
BN 52021 decreases alveolar macrophage-mediated lung injury in experimental extrinsic allergic alveolitis.
por: Tremblay, G
Publicado: (1999) -
Bleomycin-induced lung injury in the rat: effects of the platelet-activating factor (PAF) receptor antagonist BN 52021 and platelet depletion.
por: Evans, T W, et al.
Publicado: (1990) -
Spotlight on the diagnosis of extrinsic allergic alveolitis (hypersensitivity pneumonitis)
por: Baur, Xaver, et al.
Publicado: (2015) -
Expression of the Fc-receptor for IgE (Fc epsilon RII, CD23) on alveolar macrophages in extrinsic allergic alveolitis
Publicado: (1990) -
Protective effect of high concentration of BN52021 on retinal contusion in cat eyes
por: Huang, Jin-Feng, et al.
Publicado: (2015)